Xenon Pharmaceuticals Stock Today
| XENE Stock | USD 41.31 0.01 0.02% |
Performance0 of 100
| Odds Of DistressLess than 44
|
Xenon Pharmaceuticals is trading at 41.31 as of the 16th of April 2024, a 0.02 percent up since the beginning of the trading day. The stock's lowest day price was 40.62. Xenon Pharmaceuticals has about a 44 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Equity ratings for Xenon Pharmaceuticals are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 17th of March 2024 and ending today, the 16th of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 5th of November 2014 | Category Healthcare | Classification Health Care |
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Xenon Pharmaceuticals Inc. was incorporated in 1996 and is headquartered in Burnaby, Canada. The company has 75.43 M outstanding shares of which 2.76 M shares are at this time shorted by private and institutional investors with about 7.24 trading days to cover. More on Xenon Pharmaceuticals
Moving against Xenon Stock
| 0.76 | MRNA | Moderna Financial Report 2nd of May 2024 | PairCorr |
| 0.68 | INDP | Indaptus Therapeutics Financial Report 9th of May 2024 | PairCorr |
| 0.66 | CELC | Celcuity LLC Financial Report 20th of May 2024 | PairCorr |
| 0.62 | RZLT | Rezolute Trending | PairCorr |
| 0.5 | BMY | Bristol Myers Squibb Financial Report 25th of April 2024 | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Financial Report 14th of May 2024
Xenon Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Xenon Pharmaceuticals' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Xenon Pharmaceuticals or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| President CEO, Director | Simon Pimstone | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Biotechnology, NASDAQ Health Care, NASDAQ Composite, NASDAQ Composite Total, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Xenon Pharmaceuticals report their recommendations after researching Xenon Pharmaceuticals' financial statements, talking to executives and customers, or listening in on Xenon Pharmaceuticals' conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Xenon Pharmaceuticals. The Xenon consensus assessment is calculated by taking the average forecast from all of the analysts covering Xenon Pharmaceuticals. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the key indicators related to Xenon Pharmaceuticals' liquidity, profitability, solvency, and operating efficiency, Xenon Pharmaceuticals is not in a good financial situation at this time. It has a very high odds of going through financial crisis in May. Financial strength of Xenon Pharmaceuticals is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Xenon Pharmaceuticals' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Xenon Pharmaceuticals' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Xenon Pharmaceuticals' financial leverage. It provides some insight into what part of Xenon Pharmaceuticals' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Xenon Pharmaceuticals (XENE) is traded on NASDAQ Exchange in USA. It is located in 3650 Gilmore Way, Burnaby, BC, Canada, V5G 4W8 and employs 251 people. Xenon Pharmaceuticals is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 3.12 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Xenon Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Xenon Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Xenon Pharmaceuticals conducts business under Biotechnology sector and is part of Health Care industry. The entity has 75.43 M outstanding shares of which 2.76 M shares are at this time shorted by private and institutional investors with about 7.24 trading days to cover.
Xenon Pharmaceuticals currently holds about 788.24 M in cash with (145.33 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 12.66.
Check Xenon Pharmaceuticals Probability Of Bankruptcy
Ownership AllocationXenon Pharmaceuticals owns a total of 75.43 Million outstanding shares. The majority of Xenon Pharmaceuticals outstanding shares are owned by institutional investors. These institutions are usually referred to as non-private investors looking to purchase positions in Xenon Pharmaceuticals to benefit from reduced commissions. Consequently, other corporate entities are subject to a different set of regulations than regular investors in Xenon Pharmaceuticals. Please pay attention to any change in the institutional holdings of Xenon Pharmaceuticals as this could imply that something significant has changed or is about to change at the company. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Xenon Ownership Details
Xenon Stock Price Odds Analysis
What are Xenon Pharmaceuticals' target price odds to finish over the current price? Based on a normal probability distribution, the odds of Xenon Pharmaceuticals jumping above the current price in 90 days from now is over 95.38%. The Xenon Pharmaceuticals probability density function shows the probability of Xenon Pharmaceuticals stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days Xenon Pharmaceuticals has a beta of 0.9943. This entails Xenon Pharmaceuticals market returns are highly-sensitive to returns on the market. As the market goes up or down, Xenon Pharmaceuticals is expected to follow. Additionally, xenon Pharmaceuticals has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Xenon Pharmaceuticals to move above the current price in 90 days from now is over 95.38 (This Xenon Pharmaceuticals probability density function shows the probability of Xenon Stock to fall within a particular range of prices over 90 days) .
Xenon Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Xenon Pharmaceuticals that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Xenon Pharmaceuticals' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Xenon Pharmaceuticals' value.| Instituion | Recorded On | Shares | |
| Pictet Asset Manangement Sa | 2023-12-31 | 2 M | |
| Bvf Inc | 2023-09-30 | 1.8 M | |
| First Light Asset Management, Llc | 2023-12-31 | 1.6 M | |
| Alliancebernstein L.p. | 2023-12-31 | 1.6 M | |
| Marshall Wace Asset Management Ltd | 2023-12-31 | 1.5 M | |
| Rock Springs Capital Management Lp | 2023-12-31 | 1.3 M | |
| Point72 Asset Management, L.p. | 2023-09-30 | 1.1 M | |
| Perceptive Advisors Llc | 2023-12-31 | 1.1 M | |
| Adage Capital Partners Gp Llc | 2023-12-31 | 1 M | |
| Venbio Select Advisor Llc | 2023-12-31 | 5.7 M | |
| Fmr Inc | 2023-12-31 | 5.7 M |
Xenon Pharmaceuticals Historical Income Statement
Xenon Pharmaceuticals Income Statement is one of the three primary financial statements used for reporting Xenon's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Xenon Pharmaceuticals revenue and expense. Xenon Pharmaceuticals Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At present, Xenon Pharmaceuticals' Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's Selling General Administrative is expected to grow to about 48.9 M, whereas Gross Profit is projected to grow to (3.4 M). View More FundamentalsXenon Stock Against Markets
Picking the right benchmark for Xenon Pharmaceuticals stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Xenon Pharmaceuticals stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Xenon Pharmaceuticals is critical whether you are bullish or bearish towards Xenon Pharmaceuticals at a given time. Please also check how Xenon Pharmaceuticals' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Xenon Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Equity Valuation Now
Equity ValuationCheck real value of public entities based on technical and fundamental data |
| All Next | Launch Module |
Xenon Pharmaceuticals Corporate Directors
Xenon Pharmaceuticals corporate directors refer to members of a Xenon Pharmaceuticals board of directors. The board of directors generally takes responsibility for the Xenon Pharmaceuticals' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Xenon Pharmaceuticals' board members must vote for the resolution. The Xenon Pharmaceuticals board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Michael Hayden | Director | Profile | |
| Dawn Svoronos | Director | Profile | |
| Gary Patou | Director | Profile | |
| Richard Scheller | Director | Profile |
How to buy Xenon Stock?
Before investing in Xenon Pharmaceuticals, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Xenon Pharmaceuticals. To buy Xenon Pharmaceuticals stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Xenon Pharmaceuticals. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Xenon Pharmaceuticals stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Xenon Pharmaceuticals stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Xenon Pharmaceuticals stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Xenon Pharmaceuticals, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Xenon Stock please use our How to Invest in Xenon Pharmaceuticals guide.
Already Invested in Xenon Pharmaceuticals?
The danger of trading Xenon Pharmaceuticals is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Xenon Pharmaceuticals is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Xenon Pharmaceuticals. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Xenon Pharmaceuticals is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Xenon Pharmaceuticals is a strong investment it is important to analyze Xenon Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Xenon Pharmaceuticals' future performance. For an informed investment choice regarding Xenon Stock, refer to the following important reports: Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Xenon Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Xenon Stock refer to our How to Trade Xenon Stock guide.You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Complementary Tools for Xenon Stock analysis
When running Xenon Pharmaceuticals' price analysis, check to measure Xenon Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xenon Pharmaceuticals is operating at the current time. Most of Xenon Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Xenon Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xenon Pharmaceuticals' price. Additionally, you may evaluate how the addition of Xenon Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |
Is Xenon Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Xenon Pharmaceuticals. If investors know Xenon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Xenon Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.73) | Quarterly Revenue Growth (1.00) | Return On Assets (0.16) | Return On Equity (0.22) |
The market value of Xenon Pharmaceuticals is measured differently than its book value, which is the value of Xenon that is recorded on the company's balance sheet. Investors also form their own opinion of Xenon Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Xenon Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Xenon Pharmaceuticals' market value can be influenced by many factors that don't directly affect Xenon Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Xenon Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Xenon Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Xenon Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.